nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—SLC6A4—autistic disorder	0.387	0.565	CbGaD
Nefazodone—HTR2A—autistic disorder	0.298	0.435	CbGaD
Nefazodone—SLC6A3—telencephalic ventricle—autistic disorder	0.00642	0.0558	CbGeAlD
Nefazodone—HTR2C—telencephalic ventricle—autistic disorder	0.00621	0.054	CbGeAlD
Nefazodone—HTR2A—cerebellar cortex—autistic disorder	0.00536	0.0465	CbGeAlD
Nefazodone—HTR1A—telencephalic ventricle—autistic disorder	0.00523	0.0454	CbGeAlD
Nefazodone—HTR2A—pons—autistic disorder	0.00379	0.0329	CbGeAlD
Nefazodone—HTR2A—telencephalic ventricle—autistic disorder	0.00312	0.0271	CbGeAlD
Nefazodone—SLC6A3—hindbrain—autistic disorder	0.00303	0.0264	CbGeAlD
Nefazodone—SLC6A4—hindbrain—autistic disorder	0.00278	0.0242	CbGeAlD
Nefazodone—HTR1A—hindbrain—autistic disorder	0.00247	0.0214	CbGeAlD
Nefazodone—ADRA1A—hindbrain—autistic disorder	0.00227	0.0198	CbGeAlD
Nefazodone—SLC6A3—brainstem—autistic disorder	0.00174	0.0151	CbGeAlD
Nefazodone—HTR2C—brainstem—autistic disorder	0.00168	0.0146	CbGeAlD
Nefazodone—SLC6A3—forebrain—autistic disorder	0.00168	0.0146	CbGeAlD
Nefazodone—HTR2C—forebrain—autistic disorder	0.00162	0.0141	CbGeAlD
Nefazodone—SLC6A4—brainstem—autistic disorder	0.00159	0.0138	CbGeAlD
Nefazodone—SLC6A3—telencephalon—autistic disorder	0.00154	0.0134	CbGeAlD
Nefazodone—SLC6A4—forebrain—autistic disorder	0.00154	0.0134	CbGeAlD
Nefazodone—HTR2C—telencephalon—autistic disorder	0.00149	0.013	CbGeAlD
Nefazodone—HTR2A—hindbrain—autistic disorder	0.00147	0.0128	CbGeAlD
Nefazodone—HTR1A—brainstem—autistic disorder	0.00141	0.0123	CbGeAlD
Nefazodone—SLC6A4—telencephalon—autistic disorder	0.00141	0.0123	CbGeAlD
Nefazodone—SLC6A2—brainstem—autistic disorder	0.0014	0.0122	CbGeAlD
Nefazodone—HTR1A—forebrain—autistic disorder	0.00137	0.0119	CbGeAlD
Nefazodone—SLC6A2—forebrain—autistic disorder	0.00135	0.0118	CbGeAlD
Nefazodone—CYP2D6—hindbrain—autistic disorder	0.00134	0.0116	CbGeAlD
Nefazodone—ADRA1A—brainstem—autistic disorder	0.0013	0.0113	CbGeAlD
Nefazodone—ADRA1B—head—autistic disorder	0.00128	0.0111	CbGeAlD
Nefazodone—ADRA1A—forebrain—autistic disorder	0.00126	0.0109	CbGeAlD
Nefazodone—HTR1A—telencephalon—autistic disorder	0.00126	0.0109	CbGeAlD
Nefazodone—SLC6A2—telencephalon—autistic disorder	0.00124	0.0108	CbGeAlD
Nefazodone—ADRA1B—nervous system—autistic disorder	0.00122	0.0106	CbGeAlD
Nefazodone—ADRA1B—central nervous system—autistic disorder	0.00117	0.0102	CbGeAlD
Nefazodone—ADRA1A—telencephalon—autistic disorder	0.00116	0.0101	CbGeAlD
Nefazodone—SLC6A4—digestive system—autistic disorder	0.00108	0.00938	CbGeAlD
Nefazodone—SLC6A3—head—autistic disorder	0.000961	0.00835	CbGeAlD
Nefazodone—ADRA2A—forebrain—autistic disorder	0.000957	0.00831	CbGeAlD
Nefazodone—ADRA1B—brain—autistic disorder	0.000929	0.00808	CbGeAlD
Nefazodone—HTR2C—head—autistic disorder	0.000929	0.00807	CbGeAlD
Nefazodone—SLC6A3—nervous system—autistic disorder	0.000911	0.00791	CbGeAlD
Nefazodone—HTR2C—nervous system—autistic disorder	0.00088	0.00765	CbGeAlD
Nefazodone—SLC6A4—head—autistic disorder	0.00088	0.00765	CbGeAlD
Nefazodone—ADRA2A—telencephalon—autistic disorder	0.00088	0.00765	CbGeAlD
Nefazodone—SLC6A3—central nervous system—autistic disorder	0.000877	0.00762	CbGeAlD
Nefazodone—SLC6A3—cerebellum—autistic disorder	0.000857	0.00745	CbGeAlD
Nefazodone—HTR2C—central nervous system—autistic disorder	0.000848	0.00737	CbGeAlD
Nefazodone—HTR2A—brainstem—autistic disorder	0.000843	0.00732	CbGeAlD
Nefazodone—SLC6A4—nervous system—autistic disorder	0.000835	0.00725	CbGeAlD
Nefazodone—HTR2A—eye—autistic disorder	0.000821	0.00713	CbGeAlD
Nefazodone—HTR2A—forebrain—autistic disorder	0.000814	0.00707	CbGeAlD
Nefazodone—SLC6A4—central nervous system—autistic disorder	0.000804	0.00698	CbGeAlD
Nefazodone—HTR1A—head—autistic disorder	0.000782	0.00679	CbGeAlD
Nefazodone—SLC6A2—head—autistic disorder	0.000775	0.00673	CbGeAlD
Nefazodone—CYP2D6—brainstem—autistic disorder	0.000768	0.00667	CbGeAlD
Nefazodone—HTR2A—telencephalon—autistic disorder	0.000748	0.0065	CbGeAlD
Nefazodone—CYP2D6—forebrain—autistic disorder	0.000741	0.00644	CbGeAlD
Nefazodone—HTR1A—nervous system—autistic disorder	0.000741	0.00644	CbGeAlD
Nefazodone—SLC6A2—nervous system—autistic disorder	0.000735	0.00639	CbGeAlD
Nefazodone—ADRA1A—head—autistic disorder	0.000721	0.00626	CbGeAlD
Nefazodone—HTR1A—central nervous system—autistic disorder	0.000713	0.0062	CbGeAlD
Nefazodone—SLC6A2—central nervous system—autistic disorder	0.000707	0.00615	CbGeAlD
Nefazodone—CYP3A5—digestive system—autistic disorder	0.000704	0.00612	CbGeAlD
Nefazodone—HTR1A—cerebellum—autistic disorder	0.000697	0.00606	CbGeAlD
Nefazodone—SLC6A3—brain—autistic disorder	0.000696	0.00605	CbGeAlD
Nefazodone—ADRA1A—nervous system—autistic disorder	0.000683	0.00594	CbGeAlD
Nefazodone—CYP2D6—telencephalon—autistic disorder	0.000681	0.00592	CbGeAlD
Nefazodone—HTR2C—brain—autistic disorder	0.000673	0.00585	CbGeAlD
Nefazodone—ADRA1A—central nervous system—autistic disorder	0.000658	0.00571	CbGeAlD
Nefazodone—Aripiprazole—HTR3A—autistic disorder	0.000656	0.0705	CrCbGaD
Nefazodone—Aripiprazole—HTR1D—autistic disorder	0.000649	0.0697	CrCbGaD
Nefazodone—ADRA1A—cerebellum—autistic disorder	0.000643	0.00559	CbGeAlD
Nefazodone—SLC6A4—brain—autistic disorder	0.000638	0.00554	CbGeAlD
Nefazodone—Acetophenazine—DRD1—autistic disorder	0.000627	0.0674	CrCbGaD
Nefazodone—HTR2A—digestive system—autistic disorder	0.000571	0.00496	CbGeAlD
Nefazodone—HTR1A—brain—autistic disorder	0.000566	0.00492	CbGeAlD
Nefazodone—SLC6A2—brain—autistic disorder	0.000562	0.00488	CbGeAlD
Nefazodone—ADRA2A—head—autistic disorder	0.000548	0.00476	CbGeAlD
Nefazodone—ABCB1—forebrain—autistic disorder	0.000533	0.00463	CbGeAlD
Nefazodone—CYP3A4—digestive system—autistic disorder	0.000529	0.00459	CbGeAlD
Nefazodone—ADRA1A—brain—autistic disorder	0.000522	0.00454	CbGeAlD
Nefazodone—CYP2D6—digestive system—autistic disorder	0.00052	0.00452	CbGeAlD
Nefazodone—ADRA2A—nervous system—autistic disorder	0.000519	0.00451	CbGeAlD
Nefazodone—ADRA2A—central nervous system—autistic disorder	0.0005	0.00435	CbGeAlD
Nefazodone—ABCB1—telencephalon—autistic disorder	0.00049	0.00426	CbGeAlD
Nefazodone—ADRA2A—cerebellum—autistic disorder	0.000489	0.00425	CbGeAlD
Nefazodone—Domperidone—DRD3—autistic disorder	0.000484	0.052	CrCbGaD
Nefazodone—Trifluoperazine—XDH—autistic disorder	0.000475	0.051	CrCbGaD
Nefazodone—HTR2A—head—autistic disorder	0.000466	0.00405	CbGeAlD
Nefazodone—HTR2A—nervous system—autistic disorder	0.000442	0.00384	CbGeAlD
Nefazodone—HTR2A—central nervous system—autistic disorder	0.000425	0.00369	CbGeAlD
Nefazodone—CYP2D6—head—autistic disorder	0.000424	0.00369	CbGeAlD
Nefazodone—HTR2A—cerebellum—autistic disorder	0.000416	0.00361	CbGeAlD
Nefazodone—Quetiapine—HTR3A—autistic disorder	0.00041	0.0441	CrCbGaD
Nefazodone—CYP3A4—nervous system—autistic disorder	0.000409	0.00355	CbGeAlD
Nefazodone—Quetiapine—HTR1D—autistic disorder	0.000406	0.0436	CrCbGaD
Nefazodone—CYP2D6—nervous system—autistic disorder	0.000402	0.0035	CbGeAlD
Nefazodone—Zuclopenthixol—DRD1—autistic disorder	0.000397	0.0427	CrCbGaD
Nefazodone—ADRA2A—brain—autistic disorder	0.000397	0.00345	CbGeAlD
Nefazodone—CYP3A4—central nervous system—autistic disorder	0.000394	0.00342	CbGeAlD
Nefazodone—CYP2D6—central nervous system—autistic disorder	0.000387	0.00337	CbGeAlD
Nefazodone—Aripiprazole—HTR1B—autistic disorder	0.000385	0.0414	CrCbGaD
Nefazodone—CYP2D6—cerebellum—autistic disorder	0.000379	0.00329	CbGeAlD
Nefazodone—ABCB1—digestive system—autistic disorder	0.000374	0.00325	CbGeAlD
Nefazodone—Aripiprazole—DRD3—autistic disorder	0.000374	0.0402	CrCbGaD
Nefazodone—Aripiprazole—DRD1—autistic disorder	0.000367	0.0394	CrCbGaD
Nefazodone—Thioproperazine—DRD1—autistic disorder	0.000348	0.0374	CrCbGaD
Nefazodone—HTR2A—brain—autistic disorder	0.000338	0.00293	CbGeAlD
Nefazodone—Prochlorperazine—DRD3—autistic disorder	0.000333	0.0358	CrCbGaD
Nefazodone—CYP2D6—brain—autistic disorder	0.000308	0.00267	CbGeAlD
Nefazodone—ABCB1—head—autistic disorder	0.000305	0.00265	CbGeAlD
Nefazodone—Fluphenazine—DRD3—autistic disorder	0.000301	0.0324	CrCbGaD
Nefazodone—Fluphenazine—DRD1—autistic disorder	0.000296	0.0318	CrCbGaD
Nefazodone—ABCB1—nervous system—autistic disorder	0.000289	0.00251	CbGeAlD
Nefazodone—ABCB1—central nervous system—autistic disorder	0.000279	0.00242	CbGeAlD
Nefazodone—ABCB1—cerebellum—autistic disorder	0.000272	0.00237	CbGeAlD
Nefazodone—Aripiprazole—SLC6A4—autistic disorder	0.00026	0.0279	CrCbGaD
Nefazodone—Trazodone—SLC6A4—autistic disorder	0.000259	0.0278	CrCbGaD
Nefazodone—Quetiapine—HTR1B—autistic disorder	0.000241	0.0259	CrCbGaD
Nefazodone—Perphenazine—DRD1—autistic disorder	0.000234	0.0251	CrCbGaD
Nefazodone—Quetiapine—DRD3—autistic disorder	0.000234	0.0251	CrCbGaD
Nefazodone—Quetiapine—DRD1—autistic disorder	0.000229	0.0246	CrCbGaD
Nefazodone—ABCB1—brain—autistic disorder	0.000221	0.00192	CbGeAlD
Nefazodone—Zuclopenthixol—HTR2A—autistic disorder	0.000216	0.0232	CrCbGaD
Nefazodone—Aripiprazole—HTR2A—autistic disorder	0.0002	0.0215	CrCbGaD
Nefazodone—Trazodone—HTR2A—autistic disorder	0.000199	0.0214	CrCbGaD
Nefazodone—Thioproperazine—HTR2A—autistic disorder	0.00019	0.0204	CrCbGaD
Nefazodone—Fluphenazine—HTR2A—autistic disorder	0.000161	0.0173	CrCbGaD
Nefazodone—Trifluoperazine—HTR2A—autistic disorder	0.000129	0.0138	CrCbGaD
Nefazodone—Perphenazine—HTR2A—autistic disorder	0.000127	0.0137	CrCbGaD
Nefazodone—Quetiapine—HTR2A—autistic disorder	0.000125	0.0134	CrCbGaD
Nefazodone—ADRA2A—Metabolism—COMT—autistic disorder	1.14e-05	5.97e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ADSL—autistic disorder	1.14e-05	5.96e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—GSTP1—autistic disorder	1.13e-05	5.94e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—MAOA—autistic disorder	1.13e-05	5.93e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CYP19A1—autistic disorder	1.12e-05	5.88e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—AVP—autistic disorder	1.12e-05	5.88e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—POMC—autistic disorder	1.12e-05	5.88e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CACNA1C—autistic disorder	1.12e-05	5.87e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PRL—autistic disorder	1.12e-05	5.86e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IGF2—autistic disorder	1.12e-05	5.86e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—XDH—autistic disorder	1.11e-05	5.84e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PLA2G4A—autistic disorder	1.11e-05	5.81e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—CAT—autistic disorder	1.1e-05	5.78e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PLA2G4A—autistic disorder	1.1e-05	5.78e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—PIK3CG—autistic disorder	1.09e-05	5.74e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—STX1A—autistic disorder	1.09e-05	5.73e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NPAS2—autistic disorder	1.09e-05	5.73e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—APOE—autistic disorder	1.09e-05	5.69e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—ADRB2—autistic disorder	1.08e-05	5.68e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—DHFR—autistic disorder	1.08e-05	5.67e-05	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—IL2—autistic disorder	1.08e-05	5.66e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MEF2C—autistic disorder	1.08e-05	5.65e-05	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—IL2—autistic disorder	1.07e-05	5.63e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MEF2C—autistic disorder	1.07e-05	5.62e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—ADRB2—autistic disorder	1.06e-05	5.56e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—TCN2—autistic disorder	1.06e-05	5.54e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PLA2G4A—autistic disorder	1.05e-05	5.53e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—ITGB3—autistic disorder	1.05e-05	5.51e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—ITGB3—autistic disorder	1.04e-05	5.48e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—COMT—autistic disorder	1.04e-05	5.47e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—POMC—autistic disorder	1.04e-05	5.46e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PLA2G4A—autistic disorder	1.04e-05	5.46e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—GSTM1—autistic disorder	1.04e-05	5.46e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PRL—autistic disorder	1.04e-05	5.45e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GSTP1—autistic disorder	1.04e-05	5.44e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—MAOA—autistic disorder	1.03e-05	5.43e-05	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—IL2—autistic disorder	1.03e-05	5.39e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—MAPK1—autistic disorder	1.03e-05	5.38e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MEF2C—autistic disorder	1.03e-05	5.38e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—DHFR—autistic disorder	1.02e-05	5.34e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—AVP—autistic disorder	1.02e-05	5.34e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IGF2—autistic disorder	1.01e-05	5.31e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CAT—autistic disorder	1.01e-05	5.3e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ADA—autistic disorder	1.01e-05	5.28e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—ITGB3—autistic disorder	9.99e-06	5.24e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—GPX1—autistic disorder	9.96e-06	5.23e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—AVP—autistic disorder	9.96e-06	5.22e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IGF2—autistic disorder	9.91e-06	5.2e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—ADRB2—autistic disorder	9.85e-06	5.17e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HTR2A—autistic disorder	9.79e-06	5.14e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PIK3CG—autistic disorder	9.79e-06	5.14e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL2—autistic disorder	9.79e-06	5.14e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HTR2A—autistic disorder	9.74e-06	5.11e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL2—autistic disorder	9.74e-06	5.11e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PLA2G4A—autistic disorder	9.56e-06	5.02e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GSTM1—autistic disorder	9.53e-06	5e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PLA2G4A—autistic disorder	9.53e-06	5e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PLA2G4A—autistic disorder	9.36e-06	4.91e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HTR2A—autistic disorder	9.33e-06	4.89e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL2—autistic disorder	9.32e-06	4.89e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—POMC—autistic disorder	9.32e-06	4.89e-05	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—IL2—autistic disorder	9.31e-06	4.89e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TSC2—autistic disorder	9.31e-06	4.88e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MEF2C—autistic disorder	9.3e-06	4.88e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TSC2—autistic disorder	9.26e-06	4.86e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—AVP—autistic disorder	9.25e-06	4.85e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IGF2—autistic disorder	9.21e-06	4.83e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—MTHFR—autistic disorder	9.19e-06	4.82e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—RORA—autistic disorder	9.18e-06	4.82e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GPX1—autistic disorder	9.13e-06	4.79e-05	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—IL2—autistic disorder	9.12e-06	4.78e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MEF2C—autistic disorder	9.11e-06	4.78e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—APOE—autistic disorder	9.11e-06	4.78e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—LEP—autistic disorder	9.11e-06	4.78e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—ITGB3—autistic disorder	9.06e-06	4.76e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—LEP—autistic disorder	9.06e-06	4.75e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—APOE—autistic disorder	9.06e-06	4.75e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—ITGB3—autistic disorder	8.88e-06	4.66e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TSC2—autistic disorder	8.86e-06	4.65e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PLA2G4A—autistic disorder	8.7e-06	4.56e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—APOE—autistic disorder	8.67e-06	4.55e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—LEP—autistic disorder	8.67e-06	4.55e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—MAOB—autistic disorder	8.6e-06	4.51e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PRKCB—autistic disorder	8.59e-06	4.51e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—APOE—autistic disorder	8.56e-06	4.49e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PRKCB—autistic disorder	8.54e-06	4.48e-05	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—IL2—autistic disorder	8.47e-06	4.45e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MEF2C—autistic disorder	8.46e-06	4.44e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CYP19A1—autistic disorder	8.46e-06	4.44e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL2—autistic disorder	8.46e-06	4.44e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—MTHFR—autistic disorder	8.43e-06	4.42e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HTR2A—autistic disorder	8.29e-06	4.35e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL2—autistic disorder	8.28e-06	4.35e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—ITGB3—autistic disorder	8.25e-06	4.33e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—HRAS—autistic disorder	8.23e-06	4.32e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—APC—autistic disorder	8.22e-06	4.31e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PIK3CG—autistic disorder	8.22e-06	4.31e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PRKCB—autistic disorder	8.18e-06	4.29e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—APC—autistic disorder	8.18e-06	4.29e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PIK3CG—autistic disorder	8.18e-06	4.29e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—EGF—autistic disorder	8.12e-06	4.26e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—EGF—autistic disorder	8.08e-06	4.24e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TSC2—autistic disorder	8.04e-06	4.22e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—TPH2—autistic disorder	8e-06	4.2e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CYP19A1—autistic disorder	7.97e-06	4.18e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TSC2—autistic disorder	7.87e-06	4.13e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—DPYD—autistic disorder	7.87e-06	4.13e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—APOE—autistic disorder	7.87e-06	4.13e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—LEP—autistic disorder	7.87e-06	4.13e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—COMT—autistic disorder	7.87e-06	4.13e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—APOE—autistic disorder	7.84e-06	4.12e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GSTP1—autistic disorder	7.83e-06	4.11e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—APC—autistic disorder	7.83e-06	4.11e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PIK3CG—autistic disorder	7.83e-06	4.11e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—POMC—autistic disorder	7.82e-06	4.1e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—MAOA—autistic disorder	7.81e-06	4.1e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—POMC—autistic disorder	7.78e-06	4.08e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—EGF—autistic disorder	7.74e-06	4.06e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PIK3CG—autistic disorder	7.72e-06	4.05e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—LEP—autistic disorder	7.7e-06	4.04e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—APOE—autistic disorder	7.7e-06	4.04e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HTR2A—autistic disorder	7.7e-06	4.04e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL2—autistic disorder	7.69e-06	4.04e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CAT—autistic disorder	7.62e-06	4e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IGF1—autistic disorder	7.52e-06	3.95e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—MAPK1—autistic disorder	7.49e-06	3.93e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IGF1—autistic disorder	7.49e-06	3.93e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—MAPK1—autistic disorder	7.45e-06	3.91e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—POMC—autistic disorder	7.45e-06	3.91e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PTGS2—autistic disorder	7.44e-06	3.9e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PRKCB—autistic disorder	7.42e-06	3.89e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—COMT—autistic disorder	7.41e-06	3.89e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GSTP1—autistic disorder	7.38e-06	3.87e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—MAOA—autistic disorder	7.36e-06	3.86e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—POMC—autistic disorder	7.35e-06	3.86e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CACNA1C—autistic disorder	7.32e-06	3.84e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TSC2—autistic disorder	7.31e-06	3.84e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PRKCB—autistic disorder	7.26e-06	3.81e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PLA2G4A—autistic disorder	7.19e-06	3.77e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GSTM1—autistic disorder	7.19e-06	3.77e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CAT—autistic disorder	7.18e-06	3.77e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IGF1—autistic disorder	7.17e-06	3.76e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—LEP—autistic disorder	7.16e-06	3.76e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—APOE—autistic disorder	7.16e-06	3.76e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—SERPINE1—autistic disorder	7.15e-06	3.75e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—MAPK1—autistic disorder	7.13e-06	3.74e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—SERPINE1—autistic disorder	7.11e-06	3.73e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—APC—autistic disorder	7.1e-06	3.73e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PIK3CG—autistic disorder	7.1e-06	3.73e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PIK3CG—autistic disorder	7.08e-06	3.71e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—EGF—autistic disorder	7.02e-06	3.68e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—APC—autistic disorder	6.95e-06	3.65e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PIK3CG—autistic disorder	6.95e-06	3.65e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GPX1—autistic disorder	6.89e-06	3.61e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—EGF—autistic disorder	6.87e-06	3.61e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—SERPINE1—autistic disorder	6.8e-06	3.57e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PLA2G4A—autistic disorder	6.78e-06	3.56e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GSTM1—autistic disorder	6.78e-06	3.56e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—POMC—autistic disorder	6.76e-06	3.55e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PRKCB—autistic disorder	6.75e-06	3.54e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—POMC—autistic disorder	6.74e-06	3.54e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—DHFR—autistic disorder	6.66e-06	3.49e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—POMC—autistic disorder	6.62e-06	3.47e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IGF1—autistic disorder	6.5e-06	3.41e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GPX1—autistic disorder	6.49e-06	3.41e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PTEN—autistic disorder	6.48e-06	3.4e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—MAPK1—autistic disorder	6.47e-06	3.39e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—APC—autistic disorder	6.46e-06	3.39e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PIK3CG—autistic disorder	6.46e-06	3.39e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—EGF—autistic disorder	6.38e-06	3.35e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IGF1—autistic disorder	6.37e-06	3.34e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—MTHFR—autistic disorder	6.36e-06	3.34e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—MAPK1—autistic disorder	6.33e-06	3.32e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SERPINE1—autistic disorder	6.17e-06	3.24e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—POMC—autistic disorder	6.15e-06	3.23e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SERPINE1—autistic disorder	6.04e-06	3.17e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—HRAS—autistic disorder	6.01e-06	3.15e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—MTHFR—autistic disorder	5.99e-06	3.14e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—HRAS—autistic disorder	5.98e-06	3.14e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—APOE—autistic disorder	5.92e-06	3.11e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IGF1—autistic disorder	5.91e-06	3.1e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—MAPK1—autistic disorder	5.89e-06	3.09e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PTGS2—autistic disorder	5.86e-06	3.08e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL2—autistic disorder	5.78e-06	3.03e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL6—autistic disorder	5.75e-06	3.02e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL2—autistic disorder	5.75e-06	3.02e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—HRAS—autistic disorder	5.73e-06	3e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL6—autistic disorder	5.72e-06	3e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SERPINE1—autistic disorder	5.62e-06	2.95e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—APOE—autistic disorder	5.58e-06	2.93e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL2—autistic disorder	5.51e-06	2.89e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL6—autistic disorder	5.48e-06	2.88e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PTEN—autistic disorder	5.44e-06	2.86e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PTEN—autistic disorder	5.41e-06	2.84e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PTGS2—autistic disorder	5.37e-06	2.82e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PIK3CG—autistic disorder	5.34e-06	2.8e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CYP19A1—autistic disorder	5.21e-06	2.73e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—HRAS—autistic disorder	5.19e-06	2.73e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PTEN—autistic disorder	5.18e-06	2.72e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PTEN—autistic disorder	5.11e-06	2.68e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—HRAS—autistic disorder	5.09e-06	2.67e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—POMC—autistic disorder	5.08e-06	2.67e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PIK3CG—autistic disorder	5.03e-06	2.64e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL2—autistic disorder	5e-06	2.62e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL6—autistic disorder	4.97e-06	2.61e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL2—autistic disorder	4.89e-06	2.57e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL6—autistic disorder	4.87e-06	2.55e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—COMT—autistic disorder	4.85e-06	2.54e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GSTP1—autistic disorder	4.82e-06	2.53e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—MAOA—autistic disorder	4.81e-06	2.52e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—POMC—autistic disorder	4.79e-06	2.51e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HRAS—autistic disorder	4.73e-06	2.48e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PTEN—autistic disorder	4.7e-06	2.47e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CAT—autistic disorder	4.69e-06	2.46e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PTEN—autistic disorder	4.69e-06	2.46e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PTEN—autistic disorder	4.6e-06	2.42e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL2—autistic disorder	4.55e-06	2.38e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL6—autistic disorder	4.52e-06	2.37e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PLA2G4A—autistic disorder	4.43e-06	2.33e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GSTM1—autistic disorder	4.43e-06	2.33e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MAPK1—autistic disorder	4.42e-06	2.32e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MAPK1—autistic disorder	4.4e-06	2.31e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PTEN—autistic disorder	4.28e-06	2.24e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GPX1—autistic disorder	4.24e-06	2.23e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MAPK1—autistic disorder	4.21e-06	2.21e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PTGS2—autistic disorder	4.06e-06	2.13e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—MTHFR—autistic disorder	3.92e-06	2.06e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MAPK1—autistic disorder	3.82e-06	2.01e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PTGS2—autistic disorder	3.82e-06	2.01e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MAPK1—autistic disorder	3.74e-06	1.96e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—APOE—autistic disorder	3.65e-06	1.91e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HRAS—autistic disorder	3.55e-06	1.86e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PTEN—autistic disorder	3.54e-06	1.86e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HRAS—autistic disorder	3.53e-06	1.85e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MAPK1—autistic disorder	3.48e-06	1.82e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL6—autistic disorder	3.4e-06	1.78e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HRAS—autistic disorder	3.38e-06	1.77e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL6—autistic disorder	3.38e-06	1.77e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PTEN—autistic disorder	3.33e-06	1.75e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PIK3CG—autistic disorder	3.29e-06	1.73e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL6—autistic disorder	3.24e-06	1.7e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—POMC—autistic disorder	3.13e-06	1.64e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HRAS—autistic disorder	3.07e-06	1.61e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HRAS—autistic disorder	3e-06	1.58e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL6—autistic disorder	2.94e-06	1.54e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL6—autistic disorder	2.88e-06	1.51e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HRAS—autistic disorder	2.79e-06	1.46e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL6—autistic disorder	2.67e-06	1.4e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PTGS2—autistic disorder	2.5e-06	1.31e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PTEN—autistic disorder	2.18e-06	1.14e-05	CbGpPWpGaD
